• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Increased levels of nuclear androgen receptors in hyperplastic prostate of aging men.

作者信息

Grimaldo J I, Meikle A W

出版信息

J Steroid Biochem. 1984 Aug;21(2):147-50. doi: 10.1016/0022-4731(84)90375-3.

DOI:10.1016/0022-4731(84)90375-3
PMID:6207385
Abstract

Several publications indicate the dihydrotestosterone content of hyperplastic prostatic tissue from man and dog is increased. There is limited information concerning an abnormality in the androgen receptor content in this disorder. In men, we determined the androgen receptor concentration in cytosol, nuclei, the nuclear matrix, and nuclease solubilized salt extract fractions from benign prostatic hyperplasia (BPH) and normal prostate. Nine BPH cases (age 61 +/- 7, mean +/- SD) and seven controls (age 29 +/- 10.6) were compared. Prostates were obtained during autopsy performed within 12 h after death and frozen at -70 degrees C until analysis. Four grams of tissue were homogenized and centrifuged for separation of nuclei and cytosol. Androgen receptors were estimated with an improved assay procedure. The androgen receptor content per mg of DNA in whole nuclei and in the salt extract fraction (P less than 0.01 and less than 0.05 respectively) was higher in BPH cases than in controls. Cytosol did not show a significant difference. For both groups, receptors were undetectable in the nuclear matrix. We speculate that increased androgen receptor bound to chromatin of hyperplastic tissue may be causally related to the development of BPH in aging man.

摘要

相似文献

1
Increased levels of nuclear androgen receptors in hyperplastic prostate of aging men.
J Steroid Biochem. 1984 Aug;21(2):147-50. doi: 10.1016/0022-4731(84)90375-3.
2
Androgen receptor content of normal and hyperplastic human prostate.正常及增生性人类前列腺组织中的雄激素受体含量
J Clin Endocrinol Metab. 1982 Jan;54(1):17-21. doi: 10.1210/jcem-54-1-17.
3
Androgen binding sites on nuclear matrix of normal and hyperplastic human prostate.正常及增生性人类前列腺细胞核基质上的雄激素结合位点。
J Urol. 1984 Apr;131(4):806-11. doi: 10.1016/s0022-5347(17)50629-1.
4
Concentration and cellular distribution of androgen receptor in human prostatic neoplasia: can estrogen treatment increase androgen receptor content?
J Steroid Biochem. 1983 Sep;19(3):1279-90. doi: 10.1016/0022-4731(83)90151-6.
5
Androgen receptor content of the normal and hyperplastic canine prostate.正常和增生性犬前列腺的雄激素受体含量
J Clin Invest. 1978 Mar;61(3):654-60. doi: 10.1172/JCI108977.
6
Determination of androgen receptors in human benign prostatic hypertrophy with two synthetic radiolabeled ligands.
Urol Int. 1986;41(2):133-8. doi: 10.1159/000281182.
7
Cytoplasmic and nuclear androgen receptor content of normal and neoplastic human prostates and lymph node metastases of human prostatic adenocarcinoma.正常及肿瘤性人类前列腺组织以及人类前列腺腺癌淋巴结转移灶的细胞质和细胞核雄激素受体含量
J Clin Endocrinol Metab. 1980 Apr;50(4):704-11. doi: 10.1210/jcem-50-4-704.
8
Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt-resistant receptors.雄激素受体在人正常、良性增生及恶性前列腺组织中的亚细胞分布:核耐盐受体的特征
Cancer Res. 1983 Mar;43(3):1107-16.
9
Androgen binding in cytosols and nuclei of human benign hyperplastic prostatic tissue.人良性前列腺增生组织胞质溶胶和细胞核中的雄激素结合
J Endocrinol. 1978 Apr;77(1):101-10. doi: 10.1677/joe.0.0770101.
10
Characterization of the cytosol androgen receptor of the human prostate.人前列腺胞质雄激素受体的特性研究
J Clin Endocrinol Metab. 1983 Jan;56(1):113-20. doi: 10.1210/jcem-56-1-113.

引用本文的文献

1
'Andropause'--are reduced androgen levels in aging men physiologically important?“男性更年期”——老年男性雄激素水平降低在生理上重要吗?
West J Med. 1993 Nov;159(5):618-20.